STOCK TITAN

The Carlyle Group (CG) Stock News

CG Nasdaq

Welcome to our dedicated page for The Carlyle Group news (Ticker: CG), a resource for investors and traders seeking the latest updates and insights on The Carlyle Group stock.

The Carlyle Group Inc. reports developments as a global investment firm that deploys private capital through Global Private Equity, Global Credit, and Carlyle AlpInvest. Company news commonly covers financial results, fee-related earnings, fundraising, inflows, distributable earnings, shareholder updates, capital allocation, and share repurchase activity.

Carlyle updates also include partnerships that broaden private-market access for wealth and retirement channels, activity involving private equity, credit, real estate, and infrastructure strategies, and financing or transaction developments tied to its investment platform and portfolio companies.

Rhea-AI Summary

CVC Capital Partners announced a definitive agreement to acquire a majority interest in MedRisk, a leading provider of managed physical medicine services for the workers' compensation industry in the U.S. The Carlyle Group retains a significant stake and joint control. The deal aims to accelerate MedRisk's growth and enhance patient care. MedRisk manages services for over 500,000 injured workers annually across 49 states. The transaction is anticipated to close in Q2 2021, pending regulatory approvals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.19%
Tags
none
-
Rhea-AI Summary

The Carlyle Group (NASDAQ: CG) has acquired Jagex, a leading UK video game developer known for its MMORPG franchise, RuneScape. Although the financial terms were not disclosed, Jagex has over 450 employees and boasts a $1 billion franchise with nearly 300 million player accounts. The acquisition aims to leverage Carlyle's resources to enhance Jagex’s growth through R&D and increase content output. Jagex reported record subscriber numbers in 2020, with significant growth expected in the coming years as it plans to expand its portfolio and enhance game offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.17%
Tags
-
News
Rhea-AI Summary

Net Health announced its acquisition of PointRight, a provider of analytics tools for the post-acute market, enhancing its analytics capabilities. This strategic move follows previous acquisitions and aims to strengthen Net Health's position in the post-acute care sector, enabling hospital clients to better manage skilled nursing facility (SNF) networks. PointRight's tools will help SNFs improve reimbursement accuracy and reduce rehospitalization rates, supporting Medicare Advantage and Medicaid programs. Nearly 2,400 SNFs currently utilize PointRight's services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.45%
Tags
Rhea-AI Summary

ECI Software Solutions has announced the acquisition of a majority stake by Leonard Green & Partners, while Apax Partners retains a minority stake. The transaction emphasizes ECI's rapid growth in the cloud-based ERP market, with 15 acquisitions since 2017, significantly expanding its global presence. ECI serves over 22,000 customers worldwide, providing essential software solutions for small and medium-sized businesses. The partnership aims to enhance ECI's capabilities and support its future growth trajectory, benefiting both its employees and customers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.57%
Tags
-
Rhea-AI Summary

Pharmapacks, an ecommerce enablement platform, secured over $250 million from The Carlyle Group (NASDAQ: CG) to boost growth, raising its enterprise value to approximately $1.1 billion. The funds will enhance partnerships with consumer brands and expand its logistics capabilities. Pharmapacks achieved over $250 million in sales in 2019 and is on track for 60% year-over-year growth, supported by a new 230k square foot fulfillment center. Carlyle's investment underscores its commitment to fast-growing consumer brands amidst the expanding ecommerce landscape.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.97%
Tags
none
-
Rhea-AI Summary

On September 21, 2020, The Carlyle Group (NASDAQ: CG) announced a strategic growth investment in TriNetX, acquiring a majority stake in the global health research network. While the transaction details remain undisclosed, TriNetX has established a vast network of 170 healthcare organizations across 30 countries. The investment aims to enhance TriNetX's capabilities in clinical research and accelerate its growth, leveraging AI and analytics. Carlyle's involvement aligns with its long-term healthcare commitment, having invested over $15 billion in the sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.81%
Tags

FAQ

What is the current stock price of The Carlyle Group (CG)?

The current stock price of The Carlyle Group (CG) is $44.49 as of June 2, 2026.

What is the market cap of The Carlyle Group (CG)?

The market cap of The Carlyle Group (CG) is approximately 16.2B.